CIK 0000879169 · Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943136539
- Phone
- 3024986700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,959,897
- in 5 filings, $33.0M under 10b5-1 plans
Net −$32,959,897. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-31 | Clancy Paul J Director | Grant or award | +241 | $98.77 | $24K | 23,476 |
| 2025-12-31 | BAKER BROS. ADVISORS LP Director | Grant or award | +328 | 2,817,618 | ||
| 2025-12-31 | BAKER BROS. ADVISORS LP Director | Grant or award | +328 | 28,188,297 | ||
| 2025-12-31 | HARRIGAN EDMUND Director | Grant or award | +245 | $98.77 | $24K | 20,853 |
| 2025-12-19 | Tray Thomas Principal Accounting Officer | Option exercise 10b5-1 | +1,044 | $95.76 | $100K | 24,017 |
| 2025-12-19 | Tray Thomas Principal Accounting Officer | Option exercise 10b5-1 | +1,730 | $95.76 | $166K | 25,747 |
| 2025-12-19 | Tray Thomas Principal Accounting Officer | Sale 10b5-1 | −2,774 | $100.00 | $277K | 22,973 |
| 2025-12-19 | Tray Thomas Principal Accounting Officer | Option exercise · Incentive Stock Option (right to buy) 10b5-1 | −1,044 | 0 | ||
| 2025-12-19 | Tray Thomas Principal Accounting Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −1,730 | 0 | ||
| 2025-12-18 | Tray Thomas Principal Accounting Officer | Sale 10b5-1 | −600 | $98.25 | $59K | 22,973 |
| 2025-12-17 | Morrissey Michael James EVP, Head of Tech. Operations | Sale 10b5-1 | −4,323 | $97.26 | $420K | 27,507 |
| 2025-12-16 | Morrissey Michael James EVP, Head of Tech. Operations | Sale 10b5-1 | −833 | $97.42 | $81K | 85,005 |
| 2025-12-16 | Morrissey Michael James EVP, Head of Tech. Operations | Sale 10b5-1 | −53,175 | $97.29 | $5.2M | 31,830 |
| 2025-12-11 | Mayes Patrick A EVP & Chief Scientific Officer | Sale 10b5-1 | −255 | $94.94 | $24K | 60,011 |
| 2025-12-10 | Mayes Patrick A EVP & Chief Scientific Officer | Sale 10b5-1 | −5,553 | $95.58 | $531K | 60,266 |
| 2025-12-08 | Hoppenot Herve Director | Shares withheld for taxes | −2,843 | $96.70 | $275K | 326,803 |
| 2025-12-02 | Stein Steven H EVP & Chief Medical Officer | Sale 10b5-1 | −20,105 | $102.51 | $2.1M | 63,129 |
| 2025-12-01 | Hoffman Richard A. EVP & General Counsel | Grant or award | +9,466 | 9,466 | ||
| 2025-12-01 | Hoffman Richard A. EVP & General Counsel | Grant or award · Employee Stock Option (right to buy) | +43,301 | 43,301 | ||
| 2025-12-01 | Hoffman Richard A. EVP & General Counsel | Grant or award · Performance Shares | +23,665 | 23,665 |
Page 13 of 15 · 293 trades